# CTI BioPharma
 (stock symbol: CTIC) Logo in transparent PNG and SVG formats

## CTI BioPharma
 Logo icon format

### CTI BioPharma
 Logo icon format Download PNG (33.39 KB)

![CTI BioPharma
 Logo icon format Download PNG (33.39 KB)](/img/orig/CTIC-676c68ea.png)

### CTI BioPharma
 Logo icon format Download SVG (3.23 KB)

![CTI BioPharma
 Logo icon format Download SVG (3.23 KB)](/img/orig/CTIC-4d5bf5ad.svg)

## CTI BioPharma
 Logo icon format for dark backgrounds

### CTI BioPharma
 Logo icon format for dark backgrounds Download PNG (34.18 KB)

![CTI BioPharma
 Logo icon format for dark backgrounds Download PNG (34.18 KB)](/img/orig/CTIC.D-d33ed29f.png)

### CTI BioPharma
 Logo icon format for dark backgrounds Download SVG (3.23 KB)

![CTI BioPharma
 Logo icon format for dark backgrounds Download SVG (3.23 KB)](/img/orig/CTIC.D-5dfbc569.svg)

## About CTI BioPharma


CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.

1. Website domain: ctibiopharma.com
2. Employees: 121
3. Marketcap: $0.64 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
